Recombinant herpes simplex viruses vaccines and methods

Details Recombinant herpes simplex viruses vaccines and methods Recombinant herpes simplex viruses vaccines and methods

1994-07-08

2000-09-19

Mosher, Mary E.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

4242311, 4241861, 4352351, 435236, 536 2372, A61K 39245, C12N 704, C12N 700

Patent

active

06120773&

ABSTRACT:
A recombinant herpes simplex virus genome having modified .gamma..sub.1 34.5 genes incapable of expressing an active ICP34.5 gene product, vaccines comprising the recombinant herpes simplex virus genome methods for immunizing a host against the herpes simplex virus using the recombinant herpes simplex virus genome, and a method for preparing the vaccine are disclosed.

REFERENCES:
patent: 4769331 (1988-09-01), Roizman et al.
patent: 4859587 (1989-08-01), Roizman et al.
patent: 4999296 (1991-03-01), Kit et al.
patent: 5068192 (1991-11-01), Cochran
patent: 5238688 (1993-08-01), Roizman
Location and Orientation of Homologous Sequences in the Genomes of Five Herpesviruses by A.J. Davison and N.M. Wilkie, J. gen. Virol. (1983), 64, 1927-1942.
MacLean et al, J. Gen. Virol. 72: 2305-2310, 1991.
Thompson et al, Microb Pathog 1: 409-16 (abstract only cited), Aug. 1986.
Thompson et al, Virology 172: 435-450, 1989.
Ackermann et al., J. Virol., 58(3), 843-850 (1986).
Braun et al., J. Virol., 46, 103-112 (1983).
Brown et al., J. Gen. Virol., 18, 329-346 (1973).
Centifanto-Fitzgerald et al., J. Exp. Med., 155, 475-489 (1982).
Chou et al., Cell, 41, 803-811 (1985).
Chou et al., J. Virol., 57(2), 629-637 (1986).
Chou et al., J. Virol., 64(3), 1014-1020 (1990).
Deiss et al., J. Virol., 59 605-618 (1986).
Ejercito et al., J. Gen. Virol., 2, 357-364 (1968).
Field et al., J. Hygiene, 81, 267-277 (1978).
Fields et al., Eds., Fundamental Virology, Chap. 10, 161-163 (1986).
Fields et al., Eds., Field's Virology, Chap. 66, 1843-1887 (1990).
Hammer et al., J. Infect. Dis., 141(4), 436-440 (1980).
Hayward et al., Proc. Natl. Acad. Sci. (USA), 72(11), 4243-4247 (1975).
Honess et al., J. Virol., 12, 1347-1365 (1973).
Hubenthal-Voss et al., J. Virol., 62, 454-462 (1988).
Javier et al., J. Virol., 61(6), 1978-1984 (1987).
Kieff et al., J. Virol., 8, 125-132 (1971).
Larder et al., J. Gen. Virol., 67, 2501-2506 (1986).
Linnemann et al., Lancet, i. 964-966 (1978).
McGeoch et al., J. Gen. Virol., 69, 1531-1574 (1988).
McGeoch et al., Nucleic Acids Res., 14, 1727-1745 (1986).
Meignier et al., J. Infect. Diseases, 158(3), 602-614 (1988).
Meignier et al., Vaccines 87, Cold Spring Harbor Laboratory, 368-373 (1987).
Meignier et al., Virology, 162, 251-254 (1988).
Mocarski et al., Cell, 31, 89-97 (1982).
Mocarski et al., Proc. Natl. Acad. Sci. (USA), 78, 7047 (1981).
Morse et al., J. Virol., 26(2), 389-410 (1978).
Perry et al., J. Gen. Virol., 67, 2365-2380 (1986).
Perry et al., J. Gen Virol., 69, 2831-2846 (1988).
Poffenberger et al., J. Virol., 53(2), 587-595 (1985).
Poffenberger et al., Proc. Natl. Acad. Sci. (USA), 80, 2690-2694 (1983).
Post et al., Cell, 25, 227-232 (1981).
Post et al., Proc. Natl. Acad. Sci. (USA), 77(7), 4201-4205 (1980).
Sanger et al., Proc. Natl. Acad. Sci. (USA), 74, 5463-5467 (1977).
Sheldrick et al., Cold Spring Harbor Symp. Quant. Biol., 39, 667-678 (1975).
Stevens et al., J. Exp. Medicine, 133, 19-38 (1971).
Taha et al., J. Gen. Virol., 70, 705-716 (1989).
Taha et al., J. Gen. Virol., 70, 3073-3078 (1989).
Thompson et al., J. Virol., 55(2), 504-508 (1985).
Thompson et al., J. Virol., 58(1), 203-211 (1986).
Thompson et al., Virology, 131, 171-179 (1983).
Thompson et al., Virology, 131, 180-192 (1983).
Thompson et al., Virology, 172, 435-450 (1989).
Varmuza et al., Cell, 41, 793-802 (1985).
Vlazny et al., Proc. Natl. Acad. Sci. (USA), 79, 1423-1427 (1982).
Wadsworth et al., J. Virol., 15(6), 1487-1497 (1975).
Warren et al., NEJM, 298:1068-1070 (1978).
Civil Complaint filed Jul. 8, 1999 in the United States District Court for the Northern District of Illionis Eastern Division; Joany Chou (Plaintiff) v. The University of Chicago, Arch Development Corporation, Bernard Roizman and Aviron Company (Defendants); Civil Action No. 99C 4495.

Affiliated with

Also associated with

Rating

Recombinant herpes simplex viruses vaccines and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant herpes simplex viruses vaccines and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant herpes simplex viruses vaccines and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1069471